Future perspectives in melanoma research. Meeting report from the " Melanoma Bridge. Napoli, December 2nd-4th 2012"

Paolo A. Ascierto, Antonio M. Grimaldi, Nicolas Acquavella, Lorenzo Borgognoni, Luana Calabrò, Natale Cascinelli, Alessandra Cesano, Michele Del Vecchio, Alexander M. Eggermont, Mark Faries, Soldano Ferrone, Bernard A. Fox, Thomas F. Gajewski, Jérôme Galon, Sacha Gnjatic, Helen Gogas, Mohammed Kashani-Sabet, Howard L. Kaufman, James Larkin, Roger S. LoAlberto Mantovani, Kim Margolin, Cornelis Melief, Grant McArthur, Giuseppe Palmieri, Igor Puzanov, Antoni Ribas, Barbara Seliger, Jeff Sosman, Peter Suenaert, Ahmad A. Tarhini, Giorgio Trinchieri, Fernando Vidal-Vanaclocha, Ena Wang, Gennaro Ciliberto, Nicola Mozzillo, Francesco M. Marincola, Magdalena Thurin

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Recent insights into the genetic and somatic aberrations have initiated a new era of rapidly evolving targeted and immune-based treatments for melanoma. After decades of unsuccessful attempts to finding a more effective cure in the treatment of melanoma now we have several drugs active in melanoma. The possibility to use these drugs in combination to improve responses to overcome the resistance, to potentiate the action of immune system with the new immunomodulating antibodies, and identification of biomarkers that can predict the response to a particular therapy represent new concepts and approaches in the clinical management of melanoma. The third " Melanoma Research: " A bridge from Naples to the World" meeting, shortened as " Bridge Melanoma Meeting" took place in Naples, December 2 to 4th, 2012. The four topics of discussion at this meeting were: advances in molecular profiling and novel biomarkers, combination therapies, novel concepts toward integrating biomarkers and therapies into contemporary clinical management of patients with melanoma across the entire spectrum of disease stage, and the knowledge gained from the biology of tumor microenvironment across different tumors as a bridge to impact on prognosis and response to therapy in melanoma. This international congress gathered more than 30 international faculty members who in an interactive atmosphere which stimulated discussion and exchange of their experience regarding the most recent advances in research and clinical management of melanoma patients.

Original languageEnglish
Article number137
JournalJournal of Translational Medicine
Volume11
Issue number1
DOIs
Publication statusPublished - 3 Jun 2013
Externally publishedYes

Fingerprint

Biomarkers
Melanoma
Tumors
Research
Immune system
Aberrations
Pharmaceutical Preparations
Antibodies
Therapeutics
Tumor Microenvironment
Drug Combinations
Atmosphere
Immune System

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Ascierto, P. A., Grimaldi, A. M., Acquavella, N., Borgognoni, L., Calabrò, L., Cascinelli, N., ... Thurin, M. (2013). Future perspectives in melanoma research. Meeting report from the " Melanoma Bridge. Napoli, December 2nd-4th 2012". Journal of Translational Medicine, 11(1), [137]. https://doi.org/10.1186/1479-5876-11-137

Future perspectives in melanoma research. Meeting report from the " Melanoma Bridge. Napoli, December 2nd-4th 2012". / Ascierto, Paolo A.; Grimaldi, Antonio M.; Acquavella, Nicolas; Borgognoni, Lorenzo; Calabrò, Luana; Cascinelli, Natale; Cesano, Alessandra; Del Vecchio, Michele; Eggermont, Alexander M.; Faries, Mark; Ferrone, Soldano; Fox, Bernard A.; Gajewski, Thomas F.; Galon, Jérôme; Gnjatic, Sacha; Gogas, Helen; Kashani-Sabet, Mohammed; Kaufman, Howard L.; Larkin, James; Lo, Roger S.; Mantovani, Alberto; Margolin, Kim; Melief, Cornelis; McArthur, Grant; Palmieri, Giuseppe; Puzanov, Igor; Ribas, Antoni; Seliger, Barbara; Sosman, Jeff; Suenaert, Peter; Tarhini, Ahmad A.; Trinchieri, Giorgio; Vidal-Vanaclocha, Fernando; Wang, Ena; Ciliberto, Gennaro; Mozzillo, Nicola; Marincola, Francesco M.; Thurin, Magdalena.

In: Journal of Translational Medicine, Vol. 11, No. 1, 137, 03.06.2013.

Research output: Contribution to journalArticle

Ascierto, PA, Grimaldi, AM, Acquavella, N, Borgognoni, L, Calabrò, L, Cascinelli, N, Cesano, A, Del Vecchio, M, Eggermont, AM, Faries, M, Ferrone, S, Fox, BA, Gajewski, TF, Galon, J, Gnjatic, S, Gogas, H, Kashani-Sabet, M, Kaufman, HL, Larkin, J, Lo, RS, Mantovani, A, Margolin, K, Melief, C, McArthur, G, Palmieri, G, Puzanov, I, Ribas, A, Seliger, B, Sosman, J, Suenaert, P, Tarhini, AA, Trinchieri, G, Vidal-Vanaclocha, F, Wang, E, Ciliberto, G, Mozzillo, N, Marincola, FM & Thurin, M 2013, 'Future perspectives in melanoma research. Meeting report from the " Melanoma Bridge. Napoli, December 2nd-4th 2012"', Journal of Translational Medicine, vol. 11, no. 1, 137. https://doi.org/10.1186/1479-5876-11-137
Ascierto, Paolo A. ; Grimaldi, Antonio M. ; Acquavella, Nicolas ; Borgognoni, Lorenzo ; Calabrò, Luana ; Cascinelli, Natale ; Cesano, Alessandra ; Del Vecchio, Michele ; Eggermont, Alexander M. ; Faries, Mark ; Ferrone, Soldano ; Fox, Bernard A. ; Gajewski, Thomas F. ; Galon, Jérôme ; Gnjatic, Sacha ; Gogas, Helen ; Kashani-Sabet, Mohammed ; Kaufman, Howard L. ; Larkin, James ; Lo, Roger S. ; Mantovani, Alberto ; Margolin, Kim ; Melief, Cornelis ; McArthur, Grant ; Palmieri, Giuseppe ; Puzanov, Igor ; Ribas, Antoni ; Seliger, Barbara ; Sosman, Jeff ; Suenaert, Peter ; Tarhini, Ahmad A. ; Trinchieri, Giorgio ; Vidal-Vanaclocha, Fernando ; Wang, Ena ; Ciliberto, Gennaro ; Mozzillo, Nicola ; Marincola, Francesco M. ; Thurin, Magdalena. / Future perspectives in melanoma research. Meeting report from the " Melanoma Bridge. Napoli, December 2nd-4th 2012". In: Journal of Translational Medicine. 2013 ; Vol. 11, No. 1.
@article{56b7bacff8de4f9d8bb1fa02becb0ad3,
title = "Future perspectives in melanoma research. Meeting report from the {"} Melanoma Bridge. Napoli, December 2nd-4th 2012{"}",
abstract = "Recent insights into the genetic and somatic aberrations have initiated a new era of rapidly evolving targeted and immune-based treatments for melanoma. After decades of unsuccessful attempts to finding a more effective cure in the treatment of melanoma now we have several drugs active in melanoma. The possibility to use these drugs in combination to improve responses to overcome the resistance, to potentiate the action of immune system with the new immunomodulating antibodies, and identification of biomarkers that can predict the response to a particular therapy represent new concepts and approaches in the clinical management of melanoma. The third {"} Melanoma Research: {"} A bridge from Naples to the World{"} meeting, shortened as {"} Bridge Melanoma Meeting{"} took place in Naples, December 2 to 4th, 2012. The four topics of discussion at this meeting were: advances in molecular profiling and novel biomarkers, combination therapies, novel concepts toward integrating biomarkers and therapies into contemporary clinical management of patients with melanoma across the entire spectrum of disease stage, and the knowledge gained from the biology of tumor microenvironment across different tumors as a bridge to impact on prognosis and response to therapy in melanoma. This international congress gathered more than 30 international faculty members who in an interactive atmosphere which stimulated discussion and exchange of their experience regarding the most recent advances in research and clinical management of melanoma patients.",
author = "Ascierto, {Paolo A.} and Grimaldi, {Antonio M.} and Nicolas Acquavella and Lorenzo Borgognoni and Luana Calabr{\`o} and Natale Cascinelli and Alessandra Cesano and {Del Vecchio}, Michele and Eggermont, {Alexander M.} and Mark Faries and Soldano Ferrone and Fox, {Bernard A.} and Gajewski, {Thomas F.} and J{\'e}r{\^o}me Galon and Sacha Gnjatic and Helen Gogas and Mohammed Kashani-Sabet and Kaufman, {Howard L.} and James Larkin and Lo, {Roger S.} and Alberto Mantovani and Kim Margolin and Cornelis Melief and Grant McArthur and Giuseppe Palmieri and Igor Puzanov and Antoni Ribas and Barbara Seliger and Jeff Sosman and Peter Suenaert and Tarhini, {Ahmad A.} and Giorgio Trinchieri and Fernando Vidal-Vanaclocha and Ena Wang and Gennaro Ciliberto and Nicola Mozzillo and Marincola, {Francesco M.} and Magdalena Thurin",
year = "2013",
month = "6",
day = "3",
doi = "10.1186/1479-5876-11-137",
language = "English",
volume = "11",
journal = "Journal of Translational Medicine",
issn = "1479-5876",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Future perspectives in melanoma research. Meeting report from the " Melanoma Bridge. Napoli, December 2nd-4th 2012"

AU - Ascierto, Paolo A.

AU - Grimaldi, Antonio M.

AU - Acquavella, Nicolas

AU - Borgognoni, Lorenzo

AU - Calabrò, Luana

AU - Cascinelli, Natale

AU - Cesano, Alessandra

AU - Del Vecchio, Michele

AU - Eggermont, Alexander M.

AU - Faries, Mark

AU - Ferrone, Soldano

AU - Fox, Bernard A.

AU - Gajewski, Thomas F.

AU - Galon, Jérôme

AU - Gnjatic, Sacha

AU - Gogas, Helen

AU - Kashani-Sabet, Mohammed

AU - Kaufman, Howard L.

AU - Larkin, James

AU - Lo, Roger S.

AU - Mantovani, Alberto

AU - Margolin, Kim

AU - Melief, Cornelis

AU - McArthur, Grant

AU - Palmieri, Giuseppe

AU - Puzanov, Igor

AU - Ribas, Antoni

AU - Seliger, Barbara

AU - Sosman, Jeff

AU - Suenaert, Peter

AU - Tarhini, Ahmad A.

AU - Trinchieri, Giorgio

AU - Vidal-Vanaclocha, Fernando

AU - Wang, Ena

AU - Ciliberto, Gennaro

AU - Mozzillo, Nicola

AU - Marincola, Francesco M.

AU - Thurin, Magdalena

PY - 2013/6/3

Y1 - 2013/6/3

N2 - Recent insights into the genetic and somatic aberrations have initiated a new era of rapidly evolving targeted and immune-based treatments for melanoma. After decades of unsuccessful attempts to finding a more effective cure in the treatment of melanoma now we have several drugs active in melanoma. The possibility to use these drugs in combination to improve responses to overcome the resistance, to potentiate the action of immune system with the new immunomodulating antibodies, and identification of biomarkers that can predict the response to a particular therapy represent new concepts and approaches in the clinical management of melanoma. The third " Melanoma Research: " A bridge from Naples to the World" meeting, shortened as " Bridge Melanoma Meeting" took place in Naples, December 2 to 4th, 2012. The four topics of discussion at this meeting were: advances in molecular profiling and novel biomarkers, combination therapies, novel concepts toward integrating biomarkers and therapies into contemporary clinical management of patients with melanoma across the entire spectrum of disease stage, and the knowledge gained from the biology of tumor microenvironment across different tumors as a bridge to impact on prognosis and response to therapy in melanoma. This international congress gathered more than 30 international faculty members who in an interactive atmosphere which stimulated discussion and exchange of their experience regarding the most recent advances in research and clinical management of melanoma patients.

AB - Recent insights into the genetic and somatic aberrations have initiated a new era of rapidly evolving targeted and immune-based treatments for melanoma. After decades of unsuccessful attempts to finding a more effective cure in the treatment of melanoma now we have several drugs active in melanoma. The possibility to use these drugs in combination to improve responses to overcome the resistance, to potentiate the action of immune system with the new immunomodulating antibodies, and identification of biomarkers that can predict the response to a particular therapy represent new concepts and approaches in the clinical management of melanoma. The third " Melanoma Research: " A bridge from Naples to the World" meeting, shortened as " Bridge Melanoma Meeting" took place in Naples, December 2 to 4th, 2012. The four topics of discussion at this meeting were: advances in molecular profiling and novel biomarkers, combination therapies, novel concepts toward integrating biomarkers and therapies into contemporary clinical management of patients with melanoma across the entire spectrum of disease stage, and the knowledge gained from the biology of tumor microenvironment across different tumors as a bridge to impact on prognosis and response to therapy in melanoma. This international congress gathered more than 30 international faculty members who in an interactive atmosphere which stimulated discussion and exchange of their experience regarding the most recent advances in research and clinical management of melanoma patients.

UR - http://www.scopus.com/inward/record.url?scp=84878374050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878374050&partnerID=8YFLogxK

U2 - 10.1186/1479-5876-11-137

DO - 10.1186/1479-5876-11-137

M3 - Article

C2 - 23731854

AN - SCOPUS:84878374050

VL - 11

JO - Journal of Translational Medicine

JF - Journal of Translational Medicine

SN - 1479-5876

IS - 1

M1 - 137

ER -